J&J Archives — FX Audit

J&J Sales in Q4 21 Miss Estimates, Upgrade Covid-19 Vaccine Sales to $3.5B in FY22

Post author:auditor
Post published:January 25, 2022
Post category:News / Stock Market
Post comments:0 Comments
Post last modified:January 25, 2022

(Johnson&Johnson) Johnson&Johnson announced total sales of $24.80 billion in the fourth quarter of 2021, up 10.4% from the prior year but below estimates of $25.29 billion. In FY21, Johnson&Johnson posted…

J&J Gets EU Clearance for its Coronavirus Vaccine

Post author:auditor
Post published:March 11, 2021
Post category:News
Post comments:0 Comments
Post last modified:March 11, 2021

Johnson & Johnson’s coronavirus vaccine has been cleared by the European Medicines Agency, according to Bloomberg. The clearance paves the way for the first single-injection shot that will bolster the…

J&J Sales in Q4 21 Miss Estimates, Upgrade Covid-19 Vaccine Sales to $3.5B in FY22

J&J Gets EU Clearance for its Coronavirus Vaccine

Reviews

Markets

Education

Company